These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 170213)

  • 1. Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus.
    Lesnik F; Ross LJ
    Int J Cancer; 1975 Jul; 16(1):153-63. PubMed ID: 170213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marek's disease virus (MDV) antigens in the feather follicle epithelium: difference between oncogenic and nononcogenic MDV.
    Rangga-Tabbu C; Cho BR
    Avian Dis; 1982; 26(4):907-17. PubMed ID: 6297453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
    Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Testing the immunogenicity of the dermal antigen in Marek's disease virus].
    Lesnik F; Chudý D; Bogdan J; Vrtiak OJ; Rudic M
    Vet Med (Praha); 1978 Jul; 23(7):421-30. PubMed ID: 209603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed replication of Marek's disease virus following in ovo inoculation during late stages of embryonal development.
    Sharma JM
    Avian Dis; 1987; 31(3):570-6. PubMed ID: 2823773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens.
    Murthy KK; Calnek BW
    Infect Immun; 1979 Nov; 26(2):547-53. PubMed ID: 232690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Marek's disease virus-specific antigens in Marek's disease lymphoblastoid cell lines using monoclonal antibody against virus-specific phosphorylated polypeptides.
    Ikuta K; Nakajima K; Naito M; Ann SH; Ueda S; Kato S; Hirai K
    Int J Cancer; 1985 Feb; 35(2):257-64. PubMed ID: 2982746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Immunization against Marek's disease using virus specific antigens free from infectious virus.
    Lesnik F; Ross LJ
    Br J Cancer; 1975 Feb; 31(2):260-1. PubMed ID: 169863
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-idiotype antibodies to Marek's disease-associated tumour surface antigen in protection against Marek's disease.
    Dandapat S; Pradhan HK; Mohanty GC
    Vet Immunol Immunopathol; 1994 Apr; 40(4):353-66. PubMed ID: 8042285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marek's disease virus infection in the brain: virus replication, cellular infiltration, and major histocompatibility complex antigen expression.
    Gimeno IM; Witter RL; Hunt HD; Lee LF; Reddy SM; Neumann U
    Vet Pathol; 2001 Sep; 38(5):491-503. PubMed ID: 11572556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of cell-mediated immunity to Marek's disease tumor cells in chickens inoculated with Marek's disease vaccines.
    Sharma JM; Witter RL; Coulson BD
    J Natl Cancer Inst; 1978 Nov; 61(5):1273-80. PubMed ID: 213610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody directed against Marek's disease-associated tumor surface antigen can be eluted from Marek's disease tumor cells.
    Pradhan HK; Mohanty GC; Lee WY; Patnaik B
    Vet Immunol Immunopathol; 1991 Sep; 29(3-4):229-38. PubMed ID: 1659032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of virus-specific, thymus-specific and tumour-specific antigens in lymphoblastoid cell lines derived from Marek's disease lymphomas.
    Ross LJ; Powell PC; Walker DJ; Rennie M; Payne LN
    J Gen Virol; 1977 May; 35(2):219-35. PubMed ID: 69011
    [No Abstract]   [Full Text] [Related]  

  • 14. Marek's disease. XVII. Studies on virus induced-atherosclerosis.
    Pătraşcu IV
    Virologie; 1987; 38(4):245-50. PubMed ID: 2830714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens.
    Tischer BK; Schumacher D; Beer M; Beyer J; Teifke JP; Osterrieder K; Wink K; Zelnik V; Fehler F; Osterrieder N
    J Gen Virol; 2002 Oct; 83(Pt 10):2367-2376. PubMed ID: 12237417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated cytotoxic response to cells bearing Marek's disease tumor-associated surface antigen in chickens infected with Marek's disease virus.
    Sharma JM; Coulson BD
    J Natl Cancer Inst; 1977 Jun; 58(6):1647-51. PubMed ID: 68120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus.
    Nazerian K; Lee LF; Yanagida N; Ogawa R
    J Virol; 1992 Mar; 66(3):1409-13. PubMed ID: 1310755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation the immuno-protective effect of an infectious clone of meq- deleted Marek's disease virus].
    Li Y; Kang M; Su S; Ding J; Cui Z; Zhu H
    Wei Sheng Wu Xue Bao; 2010 Jul; 50(7):942-8. PubMed ID: 20815243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral T cell-mediated immunity in Marek's disease.
    Ross LJ
    Nature; 1977 Aug; 268(5621):644-6. PubMed ID: 197421
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine.
    Lee LF; Witter RL
    Avian Dis; 1991; 35(3):452-9. PubMed ID: 1659363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.